| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Drug Abuse > A Brief History of Heroin in America |
|
Advice Pool - A Brief History of Heroin in America
In the late 1800s, opium was a popular, commonly available drug. Drug users frequented opium dens which dotted the ‘Wild West’ region According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product of America. It was smuggled in and sold by Chinese immigrants who came here to work on the railroads. There is a typical picture of ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in the western cowboy drowning himself in whiskey at a bar after a rough ride on the dirt roads. It was more likely however, that he wa lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s prostrate in a dimly lit room, smoking opium in the arms of an oriental prostitute. They often spent several nights and days at the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e dens, smoking opium, until eventually, their bodies became addicted to it. Alcoholism, however, was a bigger problem in those days d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro and opium was used as a cure for alcohol addiction. In 1810, morphine, a derivative of opium, was developed as a pain killer. It el ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc iminated pain caused by medical operations and severe injuries. Soon after it was administered, it produced an intense, dream-like st easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ate of euphoria. Hence, it came to be christened “morphine”, after Morpheus, the Greek god of dreams. It was hailed by doctors as a m nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically raculous cure for pain and used extensively and freely. In the euphoria however, its detrimental addictive properties went unnoticed and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ until after the Civil War. Thousands of soldiers became morphine addicts during the civil war and within a span of ten years since i ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ts invention America was in the grip of a major morphine epidemic. In 1874, a British chemist working in London invented a new drug. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Bayer of Germany registered it as a trademark under the name “Heroin”. Shortly, it was imported into America and aggressively market dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod d to doctors and their patients as a “safe, non-addictive” substitute for morphine. For the next several decades, it was sold legally cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin all over the country by drug companies. Eventually, in 1920, the US Congress passed the Dangerous Drug Act, banning the sale of her tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen oin over the counter and making its distribution federally regulated. However, it was too late already. Tens of thousands of citizens t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel had already been addicted and a market for heroin had been created. Today this market still exists and is, in fact, ever growing. N ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust wadays, heroin is well known, and the fact that many people abuse it is also well known.
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ealth-source.info/Drug-Addiction/Introduction-to-Heroin-Addiction/">
Opiate addiction is not taken lightly, and it shouldn't be. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de Addiction to heroin or other opiate derivatives can cause severe damage to the user over long term use. Because of this, there are n elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Best Way to use your Mobile Phones GLBT Friendly Alcohol Detox Programs; Only a Few
|